EDUCATIONAL BACKGROUND
B.A. in Psychology (with High
Distinction), University of Virginia, Charlottesville, 1977
M.S. in Clinical Psychology,
University of Wisconsin, Madison, 1981
Ph.D. in Clinical
Psychology, University of Wisconsin, Madison, 1986
Post-Doctoral Fellowship in
Neuropsychology, University of California, Los Angeles, Neuropsychiatric
Institute, 1986-88
LICENSURE/DIPLOMATE
Licensed Clinical Psychologist, State of California
(PSY 10771), 1988-2017
Diplomate, American Board of Assessment Psychology,
1996
CURRENT PROFESSIONAL, CLINICAL & RESEARCH POSITIONS
Retired, December 2015
PAST PROFESSIONAL, CLINICAL & RESEARCH EXPERIENCE
Research Neuropsychologist, UCLA Semel
Institute for Neuroscience & Human Behavior, Department of Psychiatry and
Biobehavioral Sciences, University of California, Los Angeles. Asst Research
1988-1994; Assoc Research 1994-2000; Research 2000-2015.
Clinical Professor of
Psychology, Coordinator of Assessment Services, Clinical Supervisor, UCLA
Department of Psychology, University of California, Los Angeles, 1996-2015.
Director and Co-Investigator, Neuropsychological
Manifestations Study, NIAID Multicenter AIDS Cohort Study, UCLA School of
Public Health, Division of Epidemiology, University of California, Los Angeles,
1987-2015.
Clinical Professor of
Psychiatry, UCLA Semel Institute for Neuroscience & Human Behavior, UCLA
Resnick Neuropsychiatric Hospital, Department of Psychiatry and Biobehavioral
Sciences, Geffen School of Medicine at UCLA, University of California, Los
Angeles. Assistant Clinical Prof 1988-1994; Assoc Clin Prof 1994-2000; Clin
Prof 2000-2015.
Owner, Norland Software, Computer Consulting and
Software Development, Los Angeles, California, 1983-2015.
Co-Principal Investigator and Co-Director of
Post-Doctoral Training, Neuropsychology of HIV Training Grant (NIMH), UCLA
Department of Psychiatry and Biobehavioral Sciences, Neuropsychology,
University of California, Los Angeles, 1990-2014.
Co-Principal Investigator, Neurologic AIDS Research
Center. UCLA Center for Health Sciences, AIDS Clinical Trial Group, UCLA CARE
Center, University of California, Los Angeles, 2002-2008.
Director and Principal
Investigator, Neurologic AIDS Research Center. UCLA Center for Health Sciences,
AIDS Clinical Trial Group, UCLA CARE Center, University of California, Los
Angeles, 1993-2002.
Supporting Faculty,
Interdisciplinary Training in HIV/AIDS Epidemiology. UCLA School of Public
Health, University of California, Los Angeles, 1994-2006.
Neuropsychological
Consultant and Co-Investigator, Health Costs and Services Utilization Mental
Health Study (HCSUS Mental Health).
UCLA/Drew University/RAND, Los Angeles, 1994-1998.
Neuropsychological
Consultant, Women and Family Project, UCLA Department of Psychiatry and
Biobehavioral Sciences, University of California, Los Angeles, 1995-2000.
Neuropsychological
Consultant, NIDA/NIMH Study on Neurobehavioral Factors in Black Men at Risk for
AIDS, Harbor-UCLA Medical Center, Charles R. Drew Medical Center, Los Angeles,
California, 1991-1994.
Clinical Neuropsychological
Consultant, Kaiser Permanente, Long Beach, California, 1992-1994.
Neuropsychological
Consultant, Prevalence of Dementia in a Cohort of HIV-infected Persons in
Ruili, China, University of California, Berkeley, 1992-1993.
Advisor, World Health
Organization Global Programme on AIDS.
Advisor on development of tools for cross-cultural assessment of
cognitive functioning. World Health Organization, Geneva, Switzerland,
1990-1992.
Co-Investigator, American
Foundation for AIDS Research study using EEG and computerized
neuropsychological procedures for early detection of HIV dementia. University
of California, Los Angeles, California, 1988-1989.
SOCIETIES AND HONORS
American Psychological Association, Section 9, Division 12 (1978-2016); International Neuropsychological Society (1988-2016); Diplomate,
American Board of Assessment Psychology (1996-present); Fellow, American
Academy of Assessment Psychology (1997-2016); Ittleson Consulting Fellow-Group
for the Advancement of Psychiatry Committee on Aging (1992-94); Wisconsin
Alumni Research Fund Fellow (1977-79); Honors with High Distinction in
PsychologyUniversity of Virginia (1977); Phi Beta Kappa; Echols ScholarUniversity
of Virginia (1973-77)
RESEARCH AND SCIENTIFIC REVIEW BOARDS
Ad-Hoc reviewer: Archives of General Psychiatry, Cognitive
and Behavioral Neurology, Journal of Abnormal Psychology, Journal of Acquired
Immune Deficiency Syndromes, Journal of Adolescent Health, Journal of Clinical
and Experimental Neuropsychology, Journal of the International
Neuropsychological Society, Journal of Neuropsychiatry and Clinical
Neurosciences, Journal of Neuro-AIDS, Neurology, Neuropsychology, Psychological
Assessment, Scandinavian Journal of Psychology. Ad-hoc reviewer for VA
Medical Research Service, National Institute of Neurological Disorders and
Stroke, UCLA AIDS Institute, the Wellcome Trust (UK).
PROFESSIONAL SERVICE
APA Committee on
Psychological Tests and Assessment (2006-2008); Advisor, World Health
Organization Global Programme on AIDS (1990-92); Editorial board, Journal of Neuro-Behavioral HIV Medicine
(2009-2015); Consulting Editor, Psychological
Assessment (1992-96); Multicenter AIDS Cohort Study Neuropsychology Working
Group (1987-2015); Chair of Multicenter AIDS Cohort Study Neuropsychology
Working Group (1998-2011); AIDS Clinical Trials Group Neurology Core Committee
(1995-2007); UCLA Post-Doctoral Trainee Selection Committee (1994-2014); UCLA
Psychology Department Clinic Committee (1996-2015); Veterans Administration
Voluntary Service Program (1986-87)
CLINICAL TRIALS
1. Principal Investigator for
UCLA Site. Randomized, Double Blind,
Placebo Controlled Trial of Nimodipine for the Neurological Manifestations of
HIV-1 (ACTG 162). NIAID, Miles
Pharmaceuticals, Burroughs Wellcome Company, 9/93-2/94.
2. Neuropsychological
Consultant. A Phase I/II Clinical and Pharmacokinetic Trial of Pentoxifylline
in Patients with HIV-Associated Neurologic Dysfunction Receiving Concomitant
Antiretroviral Therapy. Hoechst-Roussel
Pharmaceuticals, Inc. 1994-1995.
3. Principal Investigator for
UCLA Site. A Phase II/III Double Blind Trial of Amitriptyline and Mexiletine
for Painful Neuropathy in HIV Infections (ACTG 242). NIAID, Boehringer Ingelheim Pharmaceuticals,
1994-1999.
4. Principal Investigator for
UCLA Site; Neuropsychological Consultant. A Randomized, Placebo Controlled,
Double-Blind, Dose-Finding Study of Peptide T on Neurocognitive Function in HIV
Cognitive/Motor Complex (PT-US-002).
Peptech USA, Peptech Europe, 9/95-2/96.
5. Principal Investigator for
UCLA Site; Study Neuropsychologist. Randomized, double-blinded,
placebo-controlled trial of memantine for AIDS Dementia Complex (ADC) as
concurrent therapy with best current antiretroviral therapy (ACTG 301). NIAID;
NIMH; Neurobiological Technologies Inc, 1996-2007.
6. Principal Investigator for
UCLA Site. Nerve Growth Factor for Painful Neuropathy in HIV (ACTG 291). NIAID;
Genentech, 1996-2000.
7. Co-investigator for UCLA
Site. Randomized, Double-Blind, Parallel Group, Placebo Controlled,
Tolerability, Safety and Pilot Efficacy Study of CPI-1189 in HIV Infected
Individuals with Cognitive and Motor Impairment (NARC 003). NINDS; Centaur
Pharmaceuticals, 1999-2000.
8. Protocol Neuropsychologist
and co-PI for UCLA Site. Phase II, Placebo-controlled, Double-blind Study of
The Selegiline Transdermal System (STS) in the Treatment of HIV Associated
Cognitive Impairment (ACTG A5090). NIAID, 1999-2007.
RESEARCH AWARDS
1. Principal Investigator. Computerized Assessment of Cognitive Decline
in the Aged. USPHS, 1 F32
AG05431-01. (NIH, 09/87-08/89).
2. Project Director and
Co-Investigator. The Natural History of
Acquired Immune Deficiency Syndrome (AIDS) in Homosexual Men (NIAID,
U01-AI-35040, 9/87-3/19). PI = Roger
Detels, M.D.
3. Co-Investigator. Early Detection of HIV Dementia. (AmFAR, 6/88-5/89). PI = Andrew Leuchter, M.D.
4. Principal Investigator and
Director. UCLA ACTG Neurologic Center. (NINDS 1 P01 NS32228-01, 12/93-11/02);
Co-PI and Co-Director, 12/03-9/05.
5. Co-Investigator. HIV Cost
and Services Utilization Study (HCSUS). (AHCPR/NIMH U01-HS08578, 9/94 - 8/98).
6. Principal Investigator.
Peptide T for Treatment of HIV Dementia (Peptech PT-US-002, 5/95 - 9/96).
7. Co-Principal Investigator.
Neuropsychology AIDS Fellowship (NIMH T32 MH 19535, 9/96 - 6/11).
8. Co-Investigator. 1H-MRS
Studies in HIV Dementia (NIMH R01-NS36524, 4/97-11/06). PI = Bradford Navia,
M.D.
9. Co-Investigator. HIV and
Aging: Impact on Cognition and Mortality (NIMH R03-MH086131, 10/08-9/10). PI =
Karl Goodkin, M.D., Ph.D.
10. Co-Investigator. The Impact
of Host Genetics and Stimulant Use on Neurocognition in HIV+ Adults. (NIDA
R03-DA026099, 10/08-9/10). PI = Andrew Levine, Ph.D.
11. Co-Investigator. Multicenter
AIDS Cohort Study ARRA Supplement Neuroimaging. (NIAID U01-AI35041, 6/10
5/12). PI = Charles Rinaldo, Ph.D.
12. Co-Investigator. Pathways to
HIV-associated neurocognitive disorders: a systems biology approach. (NIDA
R01-DA030913, 9/10 7/15). PI = Andrew Levine, Ph.D.
13. Co-Investigator. Cardiovascular
and HIV/AIDS effects on brain structure/function and cognition. (NIA
R01-AG034852, 9/10 8/15). PI = James Becker, Ph.D.
PUBLICATIONS
ORIGINAL ARTICLES AND
INVESTIGATIONS:
(Total citations: 11037;
h-index: 54, i10-index 89; https://scholar.google.com/citations?user=i-xQua8AAAAJ&hl=en)
1. Chapman
LJ, Chapman JP, Miller EN. Reliabilities and intercorrelations of eight measures of proneness to
psychosis. Journal of Consulting and
Clinical Psychology. 1982;50:187-195.
2. Miller EN, Chapman LJ.
Continued word association in hypothetically psychosis-prone college students. Journal of Abnormal Psychology.
1983;92:468-478.
3. Muehlenhard CL, Miller EN.
Traditional and nontraditional men's responses to women's dating initiation. Behavior Modification. 1988;12:385-403.
4. Resnick HS, Foy DW, Donahoe
CP, Miller EN. Antisocial behavior and posttraumatic stress disorder in Vietnam
veterans. Journal of Clinical Psychology.
1989;45:860-866.
5. Van Gorp WG, Miller EN, Satz
P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised
patients: a preliminary report. Journal
of Clinical and Experimental Neuropsychology. 1989;11:763-773.
6. Van Gorp WG, Satz P, Hinkin
C, Evans G, Miller EN. The neuropsychological aspects of HIV-1 spectrum
disease. Psychiatric Medicine.
1989;7:59-78.
7. Miller EN, Selnes OA,
McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG,
Visscher B. Neuropsychological performance in HIV-1 infected homosexual men:
the Multicenter AIDS Cohort Study (MACS). Neurology.
1990;40:197-203.
8. Selnes OA, Miller E,
McArthur J, Gordon B, Muņoz A, Sheridan K, Fox R, Saah AJ, the Multicenter AIDS
Cohort Study. HIV-1 infection: no evidence of cognitive decline during the
asymptomatic stages. Neurology.
1990;40:204-208.
9. American Academy of
Neurology AIDS Task Force. Nomenclature and research case definitions for
neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1)
infection. Report of a working group of the American Academy of Neurology AIDS
Task Force. Neurology.
1991;41:778-785.
10. Miller EN, Satz P, Visscher BV. Computerized and conventional neuropsychological
assessment of HIV-1 infected homosexual men. Neurology. 1991;41:1608-1616.
11. Satz P, Miller EN, Selnes
OA, Van Gorp W, D'Elia LF, Visscher B. Hand preference in homosexual men. Cortex. 1991;27:295-306.
12. Selnes OA, Jacobson L,
Machado AM, Becker JT, Wesch J, Miller EN, Visscher B, McArthur J, the
Multicenter AIDS Cohort Study. Normative data for a brief neuropsychological
screening battery. Perceptual and Motor
Skills. 1991;73:539-550.
13. van Gorp WG, Satz P, Hinkin
C, Selnes O, Miller EN, McArthur J, Cohen B, Paz D, the Multicenter AIDS Cohort
Study. Metacognition in HIV-1 seropositive asymptomatic individuals:
Self-ratings versus objective neuropsychological performance. Journal of Clinical and Experimental
Neuropsychology. 1991;13:812-819.
14. McArthur JC, Nance-Sproson
TE, Griffin DE, Hoover D, Selnes OA, Miller EN, Margolick JB, Cohen BA,
Farzadegan H, Saah A, the Multicenter AIDS Cohort Study. The diagnostic utility
of elevation in cerebrospinal fluid b2 microglobulin in HIV-1 dementia. Neurology. 1992;42:1707-1712.
15. Nuwer MR, Miller EN,
Visscher BR, Niedermeyer E, Packwood JW, Carlson LG, Satz P, Jankel W, McArthur
JC. Asymptomatic HIV infection does not cause EEG abnormalities: results from
the Multicenter AIDS Cohort Study (MACS). Neurology.
1992;42:1214-1219.
16. Riedel RR, Helmstaedter C,
Bülau P, Durwen HF, Brackmann H, Fimmers R, Clarenbach P, Miller EN, Böttcher
M. Early signs of cognitive deficits among human immunodeficiency
virus-positive hemophiliacs. Acta
Psychiatrica Scandinavica. 1992;85:321-326.
17. Hugdahl K, Satz P,
Mitrushina M, Miller EN. Left-handedness and old age: do left-handers die
earlier? Neuropsychologia.
1993;31:325-333.
18. McArthur JC, Hoover DR,
Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NMH, McArthur JH, Selnes OA,
Jacobson LP, Visscher BR, Concha M, Saah A. Dementia in AIDS patients:
incidence and risk factors. Neurology.
1993;43:2245-2252.
19. Satz P, Morgenstern H,
Miller EN, Selnes OA, McArthur JC, Cohen BA, Becker JT, Wesch J, Jacobson L,
D'Elia LF, Van Gorp W, Visscher B. Low education as a possible risk factor for
cognitive abnormalities in HIV-1: findings from the Multicenter AIDS Cohort
Study (MACS). Journal of Acquired Immune
Deficiency Syndromes. 1993;6:503-511.
20. van Gorp WG, Hinkin C, Satz
P, Miller EN, Weisman J, Holston S, Drebing C, Marcotte TD, Dixon W. Subtypes
of HIV-related neuropsychological functioning: a cluster analysis approach. Neuropsychology. 1993;7:62-72.
21. Drebing CE, Van Gorp WG,
Hinkin C, Miller EN, Satz P, Kim DS, Holston S, D'Elia LF. Confounding factors
in the measurement of depression in HIV. Journal
of Personality Assessment. 1994;62:68-83.
22. van Gorp WG, Miller EN,
Marcotte TD, Dixon W, Paz D, Selnes O, Wesch J, Becker JT, Hinkin CH,
Mitrushina M, Satz P, Weisman JD, Buckingham SL, Stenquist PK. The relationship
between age and cognitive impairment in HIV-1 infection: findings from the
Multicenter AIDS Cohort Study and a clinical cohort. Neurology.
1994;44:929-935.
23. Newton TF, Leuchter AF,
Miller EN, Weiner H. Quantitative EEG in patients with AIDS and asymptomatic
HIV infection. Clinical
Electroencephalography. 1994;25:18-25.
24. Newton TF, Leuchter AF,
Walter DO, Van Gorp WG, Morgenstern H, Miller EN, Lieb K, Visscher B, Satz P,
Weiner H. Electroencephalographic coherence in AIDS. Psychiatry Research. 1994;54:1-11.
25. Uchiyama CL, D'Elia LF,
Dellinger AM, Becker JT, Selnes OA, Wesch JE, Chen BB, Satz P, van Gorp W,
Miller EN, the Multicenter AIDS Cohort Study. Longitudinal comparison of
alternate versions of the Symbol Digit Modalities Test: issues of form
comparability and moderating demographic variables. The Clinical Neuropsychologist. 1994;8:209-218.
26. Bacellar H, Muņoz A, Miller
EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC. Temporal trends in
the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort
Study, 1985-1992. Neurology. 1994;44:1892-1900.
27. Miller EN, Fujioka TAT, Chapman LJ, Chapman JP. Psychometrically matched
tasks for assessment of hemispheric asymmetries of function. Brain and Cognition. 1995;28:1-13.
28. Uchiyama CL, D'Elia LF,
Dellinger AM, Becker JT, Selnes OA, Wesch JE, Chen BB, Satz P, van Gorp W,
Miller EN, the Multicenter AIDS Cohort Study . Alternate forms of the
auditory-verbal learning test: issues of test comparability, longitudinal
reliability, and moderating demographic variables. Archives of Clinical Neuropsychology. 1995;10:133-145.
29. Selnes OA, Galai N, Bacellar
H, Miller EN, Becker JT, Wesch J, van Gorp W, McArthur JC. Cognitive
performance after progression to AIDS: a longitudinal study from the Multicenter
AIDS Cohort Study. Neurology. 1995;46:267-275.
30. van Gorp WG, Hinkin CH,
Moore LH, Miller EN, Marcotte TD, Satz P, Weisman J. Ascertainment bias and
neuropsychological performance in HIV-1 disease. Neuropsychology.
1995;9:206-210.
31. Miller EN, Fujioka TAT, Chapman LJ, Chapman JP. Hemispheric asymmetries of
function in patients with major affective disorders. Journal of Psychiatric Research. 1995;29:173-183.
32. Schwartzman WA, Patnaik M,
Angulo FJ, Visscher BR, Miller EN, Peter JB. Bartonella (Rochalimaea) antibodies, dementia, and cat ownership among men
infected with human immunodeficiency virus.
Clinical Infectious Diseases.
1995;21:954-959.
33. Hugdahl K, Zaucha K, Satz P,
Mitrushina M, Miller EN. Left-handedness and age: comparing writing/drawing and
other manual activities. Laterality.
1996; 1: 177-183.
34. Sacktor NC, Bacellar H,
Hoover DR, Nance-Sproson TE, Selnes OA, Miller EN, Dal Pan GJ, Kleeberger C,
Brown A, Saah A, McArthur JC. Psychomotor slowing in HIV infection: a predictor
of dementia, AIDS, and death. Journal of
Neurovirology. 1996; 2: 404-410.
35. Llorente AM, Miller EN,
DElia LF, Selnes OA, Wesch J, Becker JT, Satz P for the Multicenter AIDS
Cohort Study (MACS). Slowed information processing in HIV-1 disease. Journal of Clinical and Experimental
Neuropsychology. 1998; 20: 60-72.
36. Dal Pan GJ, Farzadegan H,
Selnes OA, Hoover DR, Miller EN, Skolasky RL, Nance-Sproson TE, McArthur JC.
Sustained cognitive decline in HIV infection: relation to CD4+ cell count,
plasma viremia, and p24 antigenemia. Journal
of Neurovirology. 1998; 4: 95-99.
37. Navia BA, Dafni U, Simpson
D, Tucker T, Singer E, McArthur JC, Yiannoutsos C, Zaborski L, Lipton SA, for
the AIDS Clinical Trials Group (site Principal Investigator). A phase I/II
trial of nimodipine for HIV-related neurologic complications. Neurology, 1998; 51: 221-228.
38. Kieburtz K, Simpson D,
Yiannoutsos C, Max MB, Hall CD, Ellis RJ, Marra CM, McKendall R, Singer E, Dal
Pan GJ, Clifford DB, Tucker T, Cohen B, and the AIDS Clinical Trial Group 242
Protocol Team (site Principal Investigator). A randomized trial of
amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology, 1998; 51: 1682-1688.
39. Childs EA, Lyles RH, Selnes
OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC. Plasma viral
load and CD4 lymphocytes as predictive markers for HIV-associated dementia and
sensory neuropathy. Neurology. 1999;
52: 607-613.
40. Sacktor NC, Lyles RH,
Skolasky RL, Anderson DE, McArthur JC, McFarlane G, Selnes OA, Becker JT, Cohen
B, Wesch J, Miller EN. Combination antiretroviral therapy improves psychomotor
speed performance in HIV+ homosexual men. Neurology.
1999; 52: 1640-1647.
41. Chang L, Ernst T,
Leonido-Yee M, Witt M, Speck O, Walot I, Miller EN. Highly active
antiretroviral therapy reverses cerebral metabolite abnormalities in mild
HIV-dementia. Neurology, 1999; 53:
782-789.
42. Richardson MA, Satz P, Myers
HF, Miller EN, Bing EG, Fawzy FI, Maj M. Effects of depressed mood versus
clinical depression on neuropsychological test performance among African
American men impacted by HIV/AIDS. Journal
of Clinical and Experimental Neuropsychology, 1999; 6: 769-783.
43. Durvasula RS, Myers HF, Satz
P, Miller EN, Morgenstern H, Richardson MA, Evans G, Forney D. HIV-1, cocaine,
and neuropsychological performance in African American men. Journal of the International
Neuropsychological Society, 2000; 6: 322-335.
44. Speck O, Ernst T, Braun A,
Koch C, Miller EN, Chang L. Gender differences in the functional organization
of the brain for working memory. NeuroReport,
2000; 11: 2581-2585.
45. McArthur JC, Yiannoutsos C,
Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA,
Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, Smith ME,
Shriver S, Millar L, Clifford DB, and the AIDS Clinical Trials Group Team 291
(site Principal Investigator). A phase II trial of nerve growth factor for
sensory neuropathy associated with HIV infection. Neurology, 2000; 54: 1080-1088.
46. Durvasula RS, Miller EN,
Myers HF, Wyatt GE. Predictors of neuropsychological performance in HIV
positive women. Journal of Clinical and
Experimental Neuropsychology, 2001; 23: 149-163.
47. Sacktor N, Lyles R, Skolasky
R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, and the
Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence
changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology, 2001; 56: 257-260.
48. Volkow ND, Chang L, Wang
G-J, Fowler JS, Leonido-Yee M, Francesci D, Sedler MJ, Gatley SJ, Hitzemann R,
Ding Y-S, Logan J, Wong C, Miller EN. Association of dopamine transporter
reduction with psychomotor impairment in methamphetamine abusers. American Journal of Psychiatry, 2001;
158: 377-382.
49. Sacktor N, Tarwater PM,
Skolasky RL, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN for the
Multicenter AIDS Cohort Study (MACS). CSF antiretroviral drug penetrance and
the treatment of HIV-associated psychomotor slowing. Neurology, 2001; 57: 542-544.
50. Chang L, Speck O, Miller EN,
Braun J, Jovicich J, Koch C, Itti L, Ernst T. Neural correlates of attention
and working memory deficits in HIV patients. Neurology, 2001; 57: 1001-1007.
51. Schifitto G, Yiannoutsos C,
Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra CM, Rubin M, Cohen BA,
Tucker T, Koralnik IJ, Katzenstein D, Haidich B, Smith ME, Shriver S, Millar L,
Clifford DB, McArthur JC, and the AIDS Clinical Trials Group Team 291 (site
Principal Investigator). Long-term treatment with recombinant nerve growth
factor for HIV-associated sensory neuropathy. Neurology, 2001; 57: 1313-1316.
52. Volkow ND, Chang L, Wang GJ,
Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS,
Logan J. Loss of dopamine transporters in methamphetamine abusers recovers with
protracted abstinence. The Journal of
Neuroscience, 2001; 21: 9414-9418.
53. Chang L, Ernst T, Speck O,
Petal H, DeSilva M, Leonido-Yee M, Miller EN. Perfusion MRI and computerized
cognitive tests abnormalities in abstinent methamphetamine users. Psychiatry Research, 2002; 114: 65-79.
54. Polk S, Muņoz A, Sacktor NC,
Jenkins F, Cohen B, Miller EN, Jacobson LP. A case-control study of
HIV-1-related dementia and co-infection with HHV-8. Neurology, 2002; 59: 950-953.
55. Chang L, Ernst T, Witt MD,
Ames N, Gaiefsky M, Miller E. Relationships among brain metabolites, cognitive
function, and viral loads in antiretroviral-naive HIV patients. NeuroImage, 2002; 17: 1638-1648.
56. Chang L, Ernst T, Witt MD,
Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN.
Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months
after HAART. Antiviral Therapy, 2003;
8: 17-26.
57. Farinpour R, Miller EN, Satz
P, Selnes OA, Cohen BA, Becker JT, Skolasky RL, Visscher BR. Psychosocial risk
factors of HIV morbidity and mortality: findings from the Multicenter AIDS
Cohort Study. Journal of Clinical and
Experimental Neuropsychology, 2003; 25: 654-670.
58. Sacktor N, Skolasky RL,
Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Visscher B, Miller EN
for the Multicenter AIDS Cohort Study (MACS). Response to systemic HIV viral
load suppression correlates with psychomotor speed performance. Neurology, 2003; 61: 567-569.
59. Wang G-J, Volkow ND, Chang
L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS. Partial
recovery of brain metabolism in methamphetamine abusers after protracted
abstinence. American Journal of
Psychiatry, 2004; 161: 242-248.
60. Yiannoutsos CT, Ernst T,
Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D,
Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, Navia
BA. Regional patterns of brain metabolites in AIDS Dementia Complex. NeuroImage, 2004; 23: 928-935.
61. Chang L, Lee PL, Yiannoutsos
CT, Ernst T, Marra CM, Richards T, Kolson D, Schiffito G, Jarvik JG, Miller EN,
Lenkinski R, Gonzalez G, Navia BA for the HIV MRS Consortium. A multicenter in vivo proton-MRS study of
HIV-associated dementia and its relationship to age. NeuroImage,
2004; 23: 1336-1347.
62. Levine AJ, Miller EN, Becker
JT, Selnes OA, Cohen BA and the Multicenter AIDS Cohort Study. Normative data
for determining significance of test-retest differences on eight common
neuropsychological instruments. The
Clinical Neuropsychologist, 2004; 18(3) 373-384.
63. Chang L, Cloak C, Patterson
K, Grob C, Miller EN, Ernst T. Enlarged striatum in abstinent methamphetamine
abusers: a possible compensatory response. Biological
Psychiatry, 2005; 57: 967-974.
64. Levine AJ, Hardy DJ, Miller
E, Castellon SA, Longshore D, Hinkin CH. The effect of recent stimulant use on
sustained attention in HIV-infected adults. Journal
of Clinical and Experimental Neuropsychology, 2006; 28: 29-42.
65. Paul R, Yiannoutsos CT,
Miller EN, Singer E, Lee PL, Chang L, Marra CM, Schifitto G, Ernst T, Richards
T, Jarvik J, Price R, Myerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski R,
Cohen RA, Navia BA for the ACTG 301 and 700 teams and the HIV MRS Consortium.
Proton MRS and neurocognitive correlates in AIDS Dementia Complex: evidence of
subcortical specificity. Journal of
Neuropsychiatry and Clinical Neurosciences, 2007; 19: 283-292.
66. Levine AJ, Hinkin CH, Miller
EN, Becker JT, Selnes OA, Cohen BA for the Multicenter AIDS Cohort Study. The
generalizability of neurocognitive test/retest data derived from a nonclinical
sample for detecting change among two HIV+ cohorts. Journal of Clinical and Experimental Neuropsychology, 2007; 29:
669-678.
PMCID: PMC2863993
67. Schifitto G, Navia BA,
Yiannoutsos CT, Marra CM, Chang L, Ernst T, Miller EN, Singer E, Simpson D,
Shriver S, Gonzalez RG, Lipton SA, and the Adult AIDS Clinical Trial Group
(ACTG) 301 and 700 Teams and the HIV MRS Consortium. Memantine and
HIV-associated cognitive impairment: a neuropsychological and proton magnetic
resonance spectroscopy study. AIDS,
2007; 21: 1877-1886.
68. Schifitto G, Zhang J, Evans
SR, Sacktor N, Simpson D, Millar LL, Hung VL, Miller EN, Smith E, Ellis RJ,
Valcour V, Singer E, Marra CM, Kolson D, Weihe J, Remmel R, Katzenstein D,
Clifford DB, and the ACTG A5090 Team. A multicenter trial of Selegiline
Transdermal System for HIV-associated cognitive impairment. Neurology, 2007; 69: 1314-1321.
69. Cole MA, Margolick JB, Cox
C, Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Cohen B, Sacktor N, Miller
EN. Longitudinally preserved psychomotor speed in long-term asymptomatic
HIV-infected individuals. Neurology,
2007; 69: 2213-2220.
70. Evans SR, Yeh T, Sacktor N,
Clifford DB, Simpson D, Miller EN, Ellis RJ, Valcour V, Marra CM, Millar L,
Schifitto G, for the AIDS Clinical Trials Group and the Neurologic AIDS
Research Consortium. Selegiline Transdermal System (STS) for HIV-Associated
Cognitive Impairment: Open-Label Report of ACTG 5090. HIV Clinical Trials, 2007; 8: 437-446.
71. Chang L, Wong V, Nakama H,
Watters M, Ramones D, Miller EN, Cloak C, Ernst T. Greater than age-related
changes in brain diffusion of HIV patients after one year. Journal of Neuroimmune Pharmacology, 2008; 3: 265-274. PMCID: PMC2693362
72. Wright MJ, Woo E,
Schmitter-Edgecombe M, Hinkin CH, Miller EN, Gooding AL. The Item Specific
Deficit Approach (ISDA) to evaluating verbal memory dysfunction: Rationale,
psychometrics and application. Journal of
Clinical and Experimental Neuropsychology, 2009; 31: 790-802. PMCID: PMC2879263
73. Becker JT, Kingsley L,
Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher
BR. Vascular risk factors and human immunodeficiency virus serostatus convey
different risks for cognitive dysfunction in gay/bisexual men. Neurology, 2009; 73: 1292-1299. PMCID: PMC2764414
74. Zhao Y, Navia BA, Marra CM,
Singer EJ, Chang L, Berger J, Ellis RJ, Kolson DL, Simpson D, Miller EN, Lipton
SA, Evans SR, Schifitto G, and the Adult AIDS Clinical Trial Group (ACTG) 301
team. Memantine for AIDS Dementia Complex: Open-label report of ACTG 301. HIV Clinical Trials,2010; 11: 59-67.
PMCID: PMC2981797
75. Sacktor N, Skolasky RL, Cox
C, Selnes O, Becker JT, Cohen B, Martin-Thormeyer E, Miller EN for the
Multicenter AIDS Cohort Study (MACS). Longitudinal psychomotor speed
performance in HIV+ individuals: impact of age and serostatus. Journal of NeuroVirology, 2010;
16:335-341.
PMCID: PMC3068912
76. Becker JT, Sanders J, Madsen
SK, Ragin A, Kingsley L, Maruca V, Cohen B, Goodkin K, Martin E, Miller EN,
Sacktor N, Alger JR, Barker PB, Saharan P, Carmichael OT, Thompson PM for the
Multicenter AIDS Cohort Study. Subcortical brain atrophy persists even in
HAART-regulated HIV disease. Brain
Imaging and Behavior, 2011; 5: 77-85. PMCID: PMC3082694
77. Wright MJ, Woo E, Foley J,
Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller
EN, Hinkin CH. Antiretroviral adherence and the nature of HIV-associated verbal
memory impairment. Journal of
Neuropsychiatry and Clinical Neurosciences, 2011; 23: 324-331. PMCID: PMC3603356.
78. Chang L, Andres M, Sadino J,
Jiang CS, Nakama H, Miller E, Ernst T. Impact of Apolipoprotein E epsilon 4 and
HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain
aging. NeuroImage, 2011; 58:
1017-1027.
79. Goodkin K, Fernandez F,
Forstein M, Miller EN, Becker JT, Douaihy A, Cubano L, Santos FH, Filho NS,
Zirulnik J, Singh D. A perspective on the proposal for neurocognitive disorder
criteria in DSM-5 as applied to HIV-associated neurocognitive disorders. Neuropsychiatry, 2011; 1: 431-440. PMCID: PMC3405847
80. Ragin AB, DSouza G,
Reynolds S, Miller E, Sacktor N, Selnes OA, Martin E, Visscher BR, Becker JT.
Platelet decline as a predictor of brain injury in HIV infection. Journal of NeuroVirology, 2011; 17:
487-495.
PMCID: PMC3472427.
81. Becker JT, Maruca V,
Kingsley L, Sanders J, Alger JR, Barker P, Goodkin K, Martin E, Miller E, Ragin
A, Sacktor N, Selnes O for the Multicenter AIDS Cohort Study. Factors affecting
brain structure in men with HIV disease in the post-HAART era. Neuroradiology, 2012; 54: 113-121. Epub 2011 March 22. PMCID: PMC3154580
82. Mateen FJ, Shinohara RT,
Carone M, Miller EN, McArthur JC, Jacobson LP, Sacktor N. Neurological
disorders incidence in HIV-positive vs. HIV-negative men: Multicenter AIDS
Cohort Study, 1996-2011. Neurology,
2012; 79: 1873-1880. PMID: 23077015 PMCID: PMC3525315.
83. Levine AJ, Service S, Miller
EN, Reynolds SM, Singer EJ, Shapshak P, Martin EM, Sacktor N, Becker JT,
Jacobson LP, Thompson P, Freimer N. Genome-wide association study of
neurocognitive impairment and dementia in HIV-infected adults. American Journal of Medical Genetics B
Neuropsychiatric Genetics, 2012; 159B: 669-683. PMID: 22628157 PMCID: PMC3418456.
84. Vo QT, Cox C, Li X, Jacobson
LP, McKaig R, Sacktor N, Selnes OA, Martin E, Becker JT, Miller EN.
Neuropsychological test performance before and after HIV-1 seroconversion: the
Multicenter AIDS Cohort Study (MACS). Journal
of NeuroVirology, 2013; 19: 24-31.
PMID: 23229349. PMCID: PMC3568242.
85. Levine AJ, Horvath S, Miller
EN, Singer EJ, Shapshak P, Baldwin GC, Martinez-Maza O, Witt MD, Langfelder P.
Transcriptome analysis of HIV-infected peripheral blood monocytes: gene
transcripts and networks associated with neurocognitive functioning. Journal of Neuroimmunology, 2013;
265(1-2): 96-105. PMCID: PMC3855455.
86. Levine AJ, Reynolds S, Cox
C, Miller EN, Sinsheimer JS, Becker JT, Martin E, Sacktor E for the
Neuropsychology Working Group of the Multicenter AIDS Cohort Study. The
longitudinal and interactive effects of HIV status, stimulant use, and host
genotype upon neurocognitive functioning. Journal
of NeuroVirology, 2014; 20(3): 243-257. PMCID: PMC4040160.
87. Becker JT, Kingsley L,
Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA,
Ragin A, Sacktor N, Selnes O. Cohort profile: Recruitment cohorts in the
neuropsychological substudy of the Multicenter AIDS Cohort Study. International Journal of Epidemiology, 2015;
44: 1506-1516.
PMCID: 4681102.
88. Becker JT, Martinson JJ,
Penugonda S, Kingsley L, Molsberry S, Wolinsky S, Reynolds S, Aronow A, Levine
A, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N. No association between
ApoE alleles, HIV infection, age, neuropsychological outcome or death. Journal of NeuroVirology, 2015;
21:24-31. PMCID: 4319994.
89. Lake JE, Vo QT, Jacobson LP,
Sacktor N, Miller EN, Post WS, Becker JT, Palella FJ, Ragin A, Martin E, Munro
CA, Brown TT. Adiponectin and Interleukin-6, but not adipose tissue, are
associated with worse neurocognitive function in HIV-infected men. Antiviral Therapy, 2015; 20: 235-244.
PMCID: 4425574.
90. Mosberry SA, Lecci F,
Kingsley L, Junker B, Reynolds S, Goodkin K, Levine AJ, Martin E, Miller EN,
Munro CA, Ragin A, Sacktor N, Becker JT. Mixed membership trajectory models of
cognitive impairment in the Multicenter AIDS Cohort Study. AIDS, 2015; 29: 713-721. PMCID: PMC4743499.
91. Hines LJ, Miller EN, Hinkin
CH, Alger JR, Barker P, Goodkin K, Martin EM, Maruca V, Ragin A, Sacktor N,
Sanders J, Selnes O, Becker JT for the Multicenter AIDS Cohort Study. Cortical
brain atrophy and intra-individual variability in neuropsychological test
performance in HIV disease. Brain Imaging
and Behavior, 2016; 10: 640-651.
92. Sacktor N, Skolasky RL,
Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E.
Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS
Cohort Study. Neurology, 2016; 86:
334-340. PMCID: PMC4776086.
93. Chang L, Lohaugen GC, Douet
V, Miller EN, Skranes J, Ernest T. Neural correlates of working memory training
in HIV patients: study protocol for a randomized controlled trial. Trials, 2016: 17:62. PMCID: PMC4736265.
94. Chang L, Lohaugen GC, Andres
T, Jiang CS, Douet V, Tanizaki N, Walker C, Castillo D, Lim A, Skranes J,
Otoshi C, Miller EN, Ernst TM. Adaptive working memory training improved brain
function in human immunodeficiency virus-seropositive patients. Annals of Neurology, 2017; 81: 17-34.
PMCID: PMC5299494.
95. Lake JE, Popov M, Post WS,
Palella FJ, Sacktor N, Miller EN, Brown TT, Becker JT. Visceral fat is
associated with brain structure independent of human immunodeficiency virus
infection status. Journal of
NeuroVirology, 2017; 23: 385-393.
96. Akhtar-Khaleel WZ, Cook RL,
Shoptaw S, Miller EN, Sacktor N, Surkan PJ, Becker J, Teplin LA, Beyth RJ,
Price C, Plankey M. Association of midlife smoking status with change in processing
speed and mental flexibility among HIV-seropositive and HIV-seronegative older
men: the Multicenter AIDS Cohort Study. Journal
of NeuroVirology, 2017; 23: 239-249.
97. Monroe AK, Zhang L, Jacobson
LP, Plankey MW, Brown TT, Munro CA, Miller EN, Martin E, Becker JT, Levine AJ,
Ragin A, Sacktor NC. The association between physical activity and cognition in
men with and without HIV. HIV Medicine, 2017
Mar 13 [Epub ahead of print].
98. Goodkin K, Miller EN, Cox C,
Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC for the
Multi-Center AIDS Cohort Study (MACS). Effect of ageing on neurocognitive
function by stage of HIV infection: evidence from the Multicenter AIDS Cohort
Study. Lancet HIV, 2017 Jul 14.
99. Zhuang Y, Qiu X, Wang L, Ma
Q, Mapstone M, Luque A, Weber M, Tivarus M, Miller E, Arduino R, Zhong J,
Schifitto G. Combination antiretroviral therapy improves cognitive performance
and functional connectivity in treatment-naïve HIV-infected individuals. Journal of Neurovirology, 2017 Aug 8.
100.
Molsberry SA, Cheng Y, Kingsley L, Jacobson L, Levine AJ, Martin E,
Miller EN, Munro CA, Ragin A, Sacktor N, Becker JT for the Neuropsychology
Working Group of the MACS. Neuropsychological phenotypes among men with and
without HIV disease in the Multicenter AIDS Cohort Study. AIDS, 2018 May 11.
101.
Quach A, Horvath S, Nemanim N, Vatakis D, Witt MD, Miller EN, Detels R,
Langfelder P, Shapshak P, Singer EJ, Levine AJ. No reliable gene expression
biomarkers of current or impending neurocognitive impairment in peripheral blood
monocytes of persons living with HIV. Journal of NeuroVirology, March 2018.
102.
Maki PM, Rubin LH, Springer G, Seaberg EC, Sacktor N, Miller EN,
Valcour V, Young MA, Becker JT, Martin EM. Differences in cognitive function
between women and men with HIV. JAIDS, 2018
May 25.
103.
Jones JD, Kuhn TP, Levine A, Sacktor N, Munro CA, Teplin L, DSouza G,
Martin EM, Becker JT, Miller EN, Hinkin CH. Changes in cognition precede
changes in HRQoL among HIV+ individuals: longitudinal analysis of the
Multicenter AIDS Cohort Study. Neuropsychology,
2019; 33:370-378.
104.
Popov M, Molsberry SA, Lecci F, Junker BW, Kingsley LA, Levine A,
Martin E, Miller EN, Munro CA, Ragin A, Seaberg EC, Sacktor N, Becker JT. Brain
structural correlates of trajectories to cognitive impairment in men with and
without HIV disease. Brain Imaging and Behavior, 2019 Jan 9.
105.
Rubin LH, Springer G, Martin EM, Seaberg EC, Sacktor NC, Miller EN,
Valcour VG, Young MA, Becker JT, Maki PM. Depressive symptoms are a stronger
predictor of executive dysfunction in HIV-infected women than men. In
preparation.
106.
Thaler NS, Miller EN, Reynolds S, Cox C, Sacktor N, Becker JT, Munro
CA, Levine AJ, Martin E. Antiretroviral medication with high central nervous
system penetrance does not adversely impact neurocognition in individuals with
HIV. Submitted for publication (Neurology).
107.
Wright MJ, Miller EN, Reinhard MJ, Cottingham ME, Cox C, Reynolds S,
Martin EM, Becker JT, Selnes OA, Manly J. The role of education level and
quality in neuropsychological test performances of ethnic minorities. Submitted
to Journal of Clinical and Experimental
Neuropsychology.
NEUROPSYCHOLOGICAL TESTS AND
EDUCATIONAL MATERIALS:
1. Miller EN. Survey of Attitudes and Experiences among
Gay Men (SAE-GM). Madison, Wisconsin: University of Wisconsin; 1980.
2. Cook M, Fischer J, Miller E.
Psychology: Test Item File. Englewood
Cliffs, NJ: Prentice-Hall, Inc.; 1982.
3. Miller EN. Norsoft
Hangman. Educational software for vocabulary development (6th grade to
adult) and cognitive rehabilitation. Madison, Wisconsin: Norland Software,
1983.
4. Miller EN. Hangman
for the Superintelligent. Educational software for vocabulary development
(9th grade to adult) and cognitive rehabilitation. Madison, Wisconsin: Norland
Software, 1983.
5. Miller EN. Sleuth A Murder Mystery. Logic
puzzles. Madison, Wisconsin: Norland Software, 1983.
6. Miller EN. Foreign
Language Hangman. Educational software for teaching Introductory Spanish
and French (3rd grade to adult). Madison, Wisconsin: Norland Software, 1983.
7. Miller EN. Continued Word Association Test.
Madison, Wisconsin: University of Wisconsin; 1983.
8. Miller EN. NSTAT Statistical Package. Double
precision statistics for the IBM Personal Computer. Madison, Wisconsin: Norland
Software, 1984.
9. Miller EN. V200 Visual 200 Communications Emulator.
Madison, Wisconsin: Norland Software, 1984.
10. Miller EN, Fujioka TAT. Similarities/Line Orientation Task.
Madison, Wisconsin: University of Wisconsin; 1985.
11. Miller EN, Fujioka TAT. Word-Finding/Dot Localization Task.
Madison, Wisconsin: University of Wisconsin; 1985.
12. Miller EN. C Rapid Directory Changer. Navigate
using partial directory names. Los Angeles: Norland Software, 1989.
13. Miller EN. California
Computerized Assessment Package. Computerized reaction time assessing
multiple domains of cognitive functioning. Stimulus materials available in
English, Spanish, Norwegian and Danish. Los Angeles: Norland Software; 1990.
14. Miller EN. Decision Maze Interactive Learning System.
Customizable system for developing interactive teaching materials. Los Angeles:
Norland Software, 1992. A special
version for use in training principles of geropsychiatry was modeled for the
American Psychiatric Press.
15. Miller
EN. California Computerized Assessment
Package (CalCAP). 2nd Edition. Los Angeles: Norland Software; 1999.
FILM:
1. Executive Producer, Coffee Date [Motion Picture]. United
States: Brown Bag Productions, 2006.
2. Executive Producer, Tru Loved [Motion Picture]. United
States: Brown Bag Productions, 2008.
CHAPTERS:
1. Van Gorp WG, Hinkin C, Satz P, Miller EN, D'Elia LF. Neuropsychological findings
in HIV infection, encephalopathy and dementia. In: Parks RW, Zec RF, Wilson RS,
eds. Neuropsychology of Alzheimer's
Disease and Other Dementias. New York: Oxford Press; 1993: 153-185.
2. Miller EN, Wilkie FL.
Computerized testing to assess cognition in HIV-positive individuals. In: Grant
I, Martin A, eds. Neuropsychology of HIV
Infection: Current Research and New Directions. New York: Oxford; 1994:
161-175.
3. Selnes OA, Miller EN.
Development of a screening battery for HIV-related cognitive impairment: the
MACS experience. In: Grant I, Martin A, eds. Neuropsychology of HIV Infection: Current Research and New Directions.
New York: Oxford University Press; 1994: 176-187.
4. Flaskerud JH, Miller EN.
Psychosocial and neuropsychiatric dysfunction. In: Ungvarski PJ, Flaskerud JH,
eds. HIV/AIDS: A Guide to Primary Care
Management. 4th edition. Philadelphia: WB Saunders Company; 1998: 255-291.
5. Reinhard MJ, Satz P, Selnes
OA, Sacktor N, Cohen BA, Becker JT, & Miller EN. Brain Reserve: HIV
Morbidity and Mortality. In: Stern, Y, ed. Cognitive
Reserve. London, UK: Psychology Press, Taylor & Francis Ltd.; 2006:
207-218.
6. Miller EN. CalCAP
(California Computerized Assessment Battery). In: Kreutzer JS, DeLuca J, Caplan
B, eds. Encyclopedia of Clinical
Neuropsychology. New York: Springer; 2011.
7. Miller EN. California
Computerized Assessment Battery. In: Kreutzer JS, DeLuca J, Caplan B, eds. Encyclopedia of Clinical Neuropsychology (2nd
edition). New York: Springer; 2018. DOI: 10.1007/978-3-319-56782-2_1272-2
LETTERS TO THE EDITOR:
1. Nuwer MR, Miller EN,
Visscher BR, Satz P. Early neurologic abnormalities in HIV infection [letter]. New England Journal of Medicine.
1991;324:492-493.
2. Miller EN, Satz P, Visscher
B. Neuropsychological tests in HIV: reply from the authors [letter]. Neurology. 1992;42:2056.
3. Selnes OA, Miller EN.
Cognitive impairment in HIV infection [letter]. AIDS. 1992;6:602-604.
4. Miller EN, Satz P, Bing EG,
Van Gorp W, Morgenstern H, Visscher B. Methodological issues in the assessment
of Human Immunodeficiency Virus-related cognitive impairment [commentary]. Archives of General Psychiatry.
1992;49:586-587.
5. Nuwer MR, Miller EN,
Visscher BR, Packwood JW, Carlson LG, Satz P, Niedermeyer E, Jankel W, McArthur
JC. EEG findings in asymptomatic HIV: reply from the authors. Neurology. 1993;43:635-636.
6. Selnes OA, Miller EN.
Asymptomatic HIV-1 infection and aviation safety [consensus statement]. Aviation,Space,and Environmental Medicine.
1993;64:172-173.
7. Miller EN, Selnes OA.
Aviation safety and asymptomatic HIV-1 infection [letter]. Aviation, Space, and Environmental Medicine. 1993;64:1059-1060.
8. Miller EN, Satz P, Selnes OA. Problems with causal inference in cross-sectional
studies of HIV infection [commentary]. Journal
of Neuropsychiatry and Clinical Neurosciences. 1994;6:201-202.
9. Miller EN, Selnes OA, Satz
P. Methods of controlling for demographic differences in neuropsychological
studies of HIV infection [commentary]. AIDS.
1994;8:280-281.
PEER-REVIEWED ABSTRACTS AND
PRESENTATIONS:
1.Muehlenhard CL, Miller EN.
Traditional and nontraditional men's responses to women's dating initiation. Annual Meeting of the Association for the
Advancement of Behavior Therapy. 1983.
2.Muehlenhard CL, Scardino TJ,
Miller EN. Consequences of women's dating initiation: Two studies. Conference on Research in Family Therapy.
1985.
3.Miller EN. Hemispheric
asymmetries of function in patients with major affective disorders. Dissertation Abstracts International.
1987;47:5061B.
4.Miller EN, Satz P, Van Gorp
W, Visscher B, Dudley J. Computerized screening for HIV-related cognitive
decline in gay men. International
Conference on AIDS. 1988;3(1):378.
5.Resnick HS, Foy DW, Miller
EN, Donahoe CP. Antisocial behavior and posttraumatic stress disorder in
Vietnam veterans. Annual Meeting of the
American Psychological Association. 1988.
6.Satz P, Miller EN, Visscher
B, Van Gorp W, D'Elia LF, Dudley J. Changes in mood as a function of HIV
serostatus: A 3-year longitudinal study. International
Conference on AIDS. 1988;3(2):408.
7.Selnes O, Miller EN, Becker
JT, Cohen BA, McArthur JC, Visscher B, Gordon B, Satz P, Ginzburg HM. Normal
neuropsychological performance in healthy HIV-1 infected homosexual men: The
Multicenter AIDS Cohort Study (MACS). International
Conference on AIDS. 1988;3(2):399.
8.Leuchter AF, Newton T, Van
Gorp W, Miller EN. Early detection of HIV effects on brain function. Annual Meeting of the American Psychiatric
Association. 1989.
9.McArthur JC, Miller EN,
Selnes OA, Becker J, Cohen BA, Starkey D, Saah A, Fox R. Effects of
azidothymidine on neuropsychological performance in asymptomatic and
symptomatic HIV-1 infection. International
Conference on AIDS. 1989;5:452.
10. Miller EN, Selnes OA, Cohen
B, Becker J, Park L, Satz P, McArthur JC, Sheridan K, Visscher B. Cognitive
abnormalities as a function of HIV-1 clinical status and use of azidothymidine
(AZT): The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS. 1989;5:462.
11. Miller EN, Selnes OA,
Visscher B, McArthur JC, Satz P, Dudley J. Changes in performance on the
Trail-Making test before and after HIV-1 seroconversion and diagnosis of AIDS:
The Multicenter AIDS Cohort Study (MACS). International
Conference on AIDS. 1989;5:464.
12. Miller EN, Satz P, Van Gorp
W, Visscher B, Dudley J. Computerized screening for HIV-related cognitive
decline in gay men: Cross-sectional analyses and one-year follow-up. International Conference on AIDS.
1989;5:465.
13. Miller EN, Satz P, Visscher
B. Computerized neuropsychological assessment for HIV-related encephalopathy. Journal of Clinical and Experimental
Neuropsychology. 1989;11:34-35.
14. Selnes OA, McArthur JC,
Miller EN, Sheridan K, Becker JT, Gordon B, the Multicenter AIDS Cohort Study.
Further evidence of lack of HIV-1 related cognitive impairment during the
asymptomatic stages: The Multicenter AIDS Cohort Study (MACS). International Conference on AIDS.
1989;5:210.
15. Selnes OA, Miller EN, McArthur JC, Cohen B, Becker JT, Saah A, et al . Neuropsychological follow-up
in patients who have progressed to AIDS: The Multicenter AIDS Cohort Study
(MACS). International Conference on AIDS.
1989;5:449.
16. Selnes OA, Muņoz A, Miller
E, Cohen B, Sheridan K. HIV-1 infection: No evidence of cognitive decline
during the asymptomatic stage. Neurology.
1989;39(suppl):426.
17. Selnes OA, McArthur JC,
Miller E, Sheridan K, Gordon B, Polk BF. Longitudinal neuropsychological
assessment of healthy HIV-1 carriers: No evidence of significant cognitive
decline. Journal of Clinical and
Experimental Neuropsychology. 1989;11:78.
18. Van Gorp W, Miller EN, Satz
P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised
patients. International Conference on
AIDS. 1989;5:464.
19. Van Gorp WG, Miller EN, Satz
P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised
patients. Journal of Clinical and
Experimental Neuropsychology. 1989;11:35.
20. Visscher B, Miller EN, Satz
P, McArthur J, Selnes O, Cohen B, Becker J, English P, Nance-Sprosson L.
Neuropsychological follow-up of 1787 participants in the Multicenter AIDS
Cohort Study. International Conference on
AIDS. 1989;5:449.
21. Gallway RA, Millington JT,
Mirsky AF, Van Gorp WG, Miller EN, Wolcott CL. Neuropsychological consequences
of hyperbaric nitrogen narcosis. Annual
Meeting of the National Academy of Neuropsychology. 1990.
22. McArthur JC, Miller EN,
Selnes OA, Becker JT, Cohen BA, Starkey D, Hoover D, Saah A. Effects of
long-term zidovudine use on neuropsychological performance in the Multicenter
AIDS Cohort Study. International
Conference on AIDS. 1990;6(2):97.
23. McArthur JC, Miller EN,
McArthur JH, Margolick J, Cohen BA, Griffin DE, Nance-Sproson T, Saah A, the
Multicenter AIDS Cohort Study. CSF Beta-2 microglobulin levels in HIV-1
infection: Correlation with duration of infection and CD4 cell count. Neurology. 1990;40(suppl):237.
24. Miller EN, Satz P, Van Gorp
WG, Visscher B. Neuropsychological manifestations of HIV-1 infection:
Cross-sectional and longitudinal perspectives. Symposium on HIV:
Neurobehavioral correlates. Journal of
Clinical and Experimental Neuropsychology. 1990;12:48.
25. Selnes OA, McArthur JC,
Miller EN, Cohen B, Wesch J, Becker J, McArthur JH, Saah A, Jacobson LP. Recent
and remote syphilis and its relationship to neuropsychological test
performance. International Conference on
AIDS. 1990;6(2):169.
26. Selnes OA, McArthur JH, Fox
R, Starkey D, Miller EN, McArthur JC. Frontal lobe functioning in asymptomatic
HIV-infection. Neurology.
1990;40(suppl):426.
27. Bing EG, Miller EN, Muņoz A,
Morgenstern H, Selnes OA, Cohen BA, Becker JT, Satz P. The effect of
demographic factors on neuropsychological test performance in men at risk for
HIV infection: the Multicenter AIDS Cohort Study. International Conference on AIDS. 1991;7(2):79.
28. Gallway RA, Millington JT,
Van Gorp WG, Miller EN, Mirsky AF. Neuropsychological consequences of
hyperbaric nitrogen narcosis II. Journal
of Clinical and Experimental Neuropsychology. 1991;13:440.
29. Selnes OA, McArthur JC,
Gordon B, Miller EN, McArthur JH, Saah A. Patterns of cognitive decline in
incident HIV-dementia: Longitudinal observations from the Multicenter AIDS
Cohort Study [Presentation]. Neurology.
1991;41 (Suppl 1):252.
30. Visscher B, Morgenstern H,
Miller EN, Satz P, Jin S, Jacobson L, Selnes O, Becker J, Cohen B, the
Multicenter AIDS Cohort Study. Relationship of HIV serostatus and education
with neuropsychological impairment in asymptomatic men. International Conference on AIDS. 1991;7(1):209.
31. Bacellar H, McArthur JC,
Hoover DR, Miller EN, Selnes OA, Cohen BA, Becker JT, Jacobson L, Saah A.
Incidence, prevalence and risk of HIV dementia in homosexual men. Annual Meeting of the American Public Health
Assocation. 1992.
32. Drebing C, Van Gorp W,
Hinkin C, Miller E, Satz P, Kim D. MMPI item analysis and the nature of the
depression in HIV. Journal of Clinical
and Experimental Neuropsychology. 1992;14:78-79.
33. Hinkin CH, Van Gorp WG, Satz
P, Miller E, Drebing C, Weisman J, Holston SG. Subject ascertainment bias and
neuropsychological performance in HIV disease. Journal of Clinical and Experimental Neuropsychology. 1992;14:79.
34. McArthur JC, Hoover DR,
Bacellar H, Miller EN, Selnes OA, Cohen BA, Becker JT, Jacobson L, Saah A. Risk
factors for development of HIV dementia in homosexual men: report from the
Multicenter AIDS Cohort Study. International
Conference on AIDS. 1992;8(2):220.
35.
Miller EN. Use of
computerized reaction time in the assessment of dementia. Neurology. 1992;42:220.
36. Pontón MO, Herrera L, Satz P, Miller EN, D'Elia LF. Neuropsychological impairment
among HIV infected Spanish-speaking subjects. The Clinical Neuropsychologist. 1992; 6: 332.
37. Pontón MO, Herrera L, Satz P, Young R, Miller EN, D'Elia LF. Neuropsychological
impairment among HIV infected Spanish-speaking subjects. Presented at the 100th
Annual Meeting of the American Psychological Association, Washington, DC. 1992.
38. Van Gorp WG, Hinkin CH, Satz
P, Miller E, Drebing C, Weisman J, Holston S, Marcotte T, Dixon W. Subtypes of
HIV-associated neuropsychological performance: a cluster-analytic approach. Journal of Clinical and Experimental
Neuropsychology. 1992;14:101.
39. Hugdahl K, Satz P,
Mitrushina M, Miller E. Incidence of left-handedness in young and old
individuals. Journal of Clinical and
Experimental Neuropsychology. 1993;15:26.
40. Miller EN, Bing EG, Selnes
OA, Wesch J, Becker JT. The effects of sociodemographic factors on reaction
time and speed of information processing. Journal
of Clinical and Experimental Neuropsychology. 1993;15:66.
41. Miller EN, Selnes OA, Visscher BR. Cognition in asymptomatic HIV-1 infection: four-year
longitudinal follow-up of AIDS-free subjects in the Multicenter AIDS Cohort
Study (MACS). International Conference on
AIDS. 1993;9(1):425.
42. Selnes OA, Galai N, McArthur
JC, Miller EN, Bacellar H, Cohen B, Wesch JE, Becker JT, Palenicek JG.
Cognitive changes with progression to AIDS: a longitudinal study from the
Multicenter AIDS Cohort Study (MACS). International
Conference on AIDS. 1993;9(1):61.
43. Miller EN, Visscher BR, Bing
EG, McArthur JC, Cohen BA, Anderson R. Co-occurrence of HIV-associated
cognitive/motor complex and other AIDS-defining illnesses. First National Conference on Human Retroviruses and Related Infections.
1993;1:143.
44. Bacellar H, McArthur JC,
Muņoz A, Cohen BA, Miller EN, Becker JT. Temporal trends in incidence of
neurological diseases in AIDS. First
National Conference on Human Retroviruses and Related Infections.
1993;1:181.
45. Martin E, Miller EN.
Contributions of cognitive neuropsychology to the study of dementia
(symposium). Annual Meeting of the
International Neuropsychological Society. Cincinnati, Ohio. February 1994,
pp. 108-109.
46. Bacellar H, Muņoz A, Miller
EN, Cohen BA, Besley D, Selnes OA, Becker JT, McArthur JC. Temporal trends in
the incidence of HIV-1 related neurologic diseases: Multicenter AIDS Cohort Study,
1985-1992. Pathogenesis of HIV infection of the Brain: Impact on Function and
Behavior. National Institute of Mental Health. April 1994, p. 16.
47. Miller EN. Pattern and
prevalence of HIV-1-associated cognitive impairment: results from the MACS. Neuropsychopharmacology. 1994;10:643S.
48. van Gorp W, Marcotte T, Satz
P, Miller E, Selnes O, Wesch J, Becker J, Jacobson L, Morgenstern H, Visscher
B. Evidence for cognitive reserve in HIV infection: Additional findings from
the Multicenter AIDS Cohort Study (MACS). Journal
of the International Neuropsychological Society. 1995;1:379.
49. Miller EN. Cognitive testing
using reaction time and traditional neuropsychological procedures. Journal of the International
Neuropsychological Society. 1995;1:393.
50. Stern MJ, Miller EN,
McArthur JC, Chen BB, Galai N, Becker JT, Cohen BA. Immune markers of
neuropsychological status: a report from the Multicenter AIDS Cohort Study. Neurology. 1995;45:A443.
51. Durvasula RS, Satz P, Hinkin
CH, Uchiyama C, Morgenstern H, Miller EN, Jin S, Sorenson D, Van Gorp W,
Visscher BR, Mitchell M. Does practice make perfect? Results of a six year
longitudinal study with semi-annual testings. Archives of Clinical Neuropsychology. 1996; 11: 386.
52. Cohen BA, Chmiel J, McArthur
JC, Chu C, Miller EN, Selnes O, Becker JT, Wesch J, Phair JP. Factors affecting
survival after diagnosis of AIDS dementia in the Multicenter AIDS Cohort Study
(MACS). Presented at the American Academy of Neurology, 1996.
53. Sacktor NC, Bacellar H,
Hoover DR, Selnes OA, Miller EN, Brown A, DalPan GJ, Nance-Sproson TE, McArthur
JC. Psychomotor slowing in HIV infection predicts onset of dementia. Presented
at the American Academy of Neurology, 1996.
54. Nance-Sproson TE, Dal Pan
GJ, Hoover DR, Miller EN, McArthur JC. Projecting risks and morbidity from
HIV-associated sensory neuropathy in the Multicenter AIDS Cohort Study (MACS). Presented at the Neuroscience of HIV
Infection, Paris, 1996.
55. Sacktor NC, Bacellar H,
Hoover DR, Selnes OA, Miller EN, Brown A, Dal Pan GJ, Nance-Sproson TE, McArthur
JC. Psychomotor slowing in HIV infection predicts increased risk of dementia,
AIDS, and death. Presented at the Neuroscience of HIV Infection, Paris, 1996.
56. Uchiyama CL, DElia LF,
Dellinger AM, Becker JT, Selnes OA, Wesch JE, Chen BB, Satz P, van Gorp W,
Miller EN, Cipani E, Spooner F. Treating problem behaviors maintained by
negative reinforcement. Research in Developmental Disabilities, 1997: 18(5).
57. Durvasula RS, Miller EN,
Wyatt GE. Neuropsychological performance in HIV positive women. Symposium
presentation. Women and HIV Conference, Pasadena, California, May 5, 1997.
58. Durvasula RS, Miller EN,
Myers HM, Satz P, Wyatt G. Neuropsychological performance and HIV-1 in ethnic
minority samples of women and men: serostatus effects, comparative data and
methodological considerations. Journal of
the International Neuropsychological Society, 4(1): 77, 1998.
59. Durvasula RS, Miller EN,
Wyatt GE. Longitudinal assessment of neuropsychological performance in HIV+
women (baseline and 6 months). Presented at the 12th World AIDS
Conference, Geneva, Switzerland, International
Conference on AIDS, 12:470, 1998.
60. Sacktor NC, Skolasky R,
Lyles R, McFarlane G, Anderson DE, Miller EN, Selnes OA, McArthur JC. Highly
active antiretroviral therapy (HAART) improves cognitive impairment in HIV+
homosexual men. Presented at the Neuroscience of HIV Infection, Chicago, Journal of Neurovirology, 4(suppl): 365,
1998.
61. Childs E, Lyles RH, Miller
EN, Cohen BA, Chen BB, Mellors J, McArthur JC. Predictive markers for
HIV-associated dementia and sensory neuropathy. Presented at the 12th
World AIDS Conference, Geneva, Switzerland, 1998.
62. Lee L, Ernst T, Yiannoutsos
C, Miller EN, Chang L, Lenkenski R, Gonzalez RG, Navia B and the HIV MRS
Research Consortium. A multicenter proton magnetic resonance spectroscopy
(1HMRS) study of HIV brain injury. Presented at the Neuroscience of HIV
Infection, Chicago, 1998.
63. Chang L, Ernst T,
Leonido-Yee M, Walot I, Miller EN, Singer E. Cerebral metabolite abnormalities
correlate with clinical severity of HIV-1 cognitive motor complex. Presented at
the Neuroscience of HIV Infection, Chicago. Journal
of Neurovirology, 4(suppl): 345, 1998.
64. Chang L, Ernst T, Leonido-Yee
M, Witt M, Speck O, Miller E. Reversal of cerebral metabolite abnormalities
with highly active antiretroviral therapy (HAART) in HIV-1 dementia. Presented
at the 7th Annual UCLA AIDS Institute Scientific Symposium, Los
Angeles, 1998.
65. Chang L, Speck O, Miller E,
Braun A, Itti L, Ernst T. Increased usage of brain reserve capacity in patients
with early stages of HIV-Cognitive Motor Complex. Presented at the 7th
Annual UCLA AIDS Institute Scientific Symposium, Los Angeles, 1998.
66. Durvasula RS, Miller EN,
Wyatt G. Neuropsychological performance in HIV+ women: baseline data. Journal of the International
Neuropsychological Society, 5(2): 97, 1999.
67. Farinpour R, Miller EN,
Castellon S. Depressive symptoms as predictors of HIV morbidity and mortality.
Presented at the National Academy of Neuropsychology, Washington, DC, 1999.
68. Farinpour R, Miller EN, Satz
P. Cognitive and psychosocial risk factors of HIV morbidity and mortality. Journal of the International
Neuropsychological Society, 5(2): 154, 1999.
69. Sacktor N, Skolasky R, Lyles
R, McFarlane G, Anderson D, Miller EN, Selnes O, Becker J, Wesch J, McArthur J.
HIV-associated psychomotor slowing improves with combination antiretroviral
therapy. Presented at the American Neuropsychiatric Association Meeting, 1999.
70. Sacktor NC, Lyles RH,
McFarlane G, Skolasky RL, Kleeberger C, Becker JT, Cohen B, Wesch J, Miller EN,
McArthur JC. The changing incidence of HIV-1-related neurological diseases:
1990-1997. Presented at the 6th Conference on Retroviruses and Opportunistic
Infections, Chicago, 1999.
71. Navia BA, Lee PL, Chang L,
Ernst T, Miller E, Kolson D, Marra C, Jarvik J, Todd R, Schifitto G, Swindells
S, McConnell J, Yiannoutsos C, Lenkinski R, Gonzalez G and the HIV MRS
Consortium. Metabolite changes in the
basal ganglia provide a signature for the AIDS Dementia Complex: a multicenter
proton magnetic resonance study. Presented at the annual meeting of the American
Academy of Neurology, Toronto. Neurology,
52: 254, 1999.
72. Yiannoutsos C, Miller E,
Chang L, Ernst T, Kolson D, Marra C, Jarvik J, Richards T, Schifitto G,
Swindells S, McConnell J, Lee PL, Gonzalez G, Rajicic N, Lenkinski R, Navia BA, and the HIV MRS Consortium. Proton
MRS and neuropsychological assessments in AIDS Dementia Complex: a measure of
subcortical function. Presented at the annual meeting of the American Academy
of Neurology, Toronto. Neurology, 52:
253-254, 1999.
73. Sacktor N, Lyles RH,
McFarlane G, Skolasky RL, Kleeberger C, Becker JT, Cohen B, Wesch J, Miller EN,
McArthur JC, and the Multicenter AIDS Cohort Study. HIV-1-related neurological
disease incidence changes in the era of highly active antiretroviral therapy.
Presented at the annual meeting of the American Academy of Neurology, Toronto. Neurology, 52: 252-253, 1999.
74. Chang L, Speck O, Miller E,
Leonido-Yee M, Patel H, Ernst T. Cerebral perfusion abnormalities and gender
effects in abstinent methamphetamine users. Presented at the annual College on
Problems of Drug Dependence meeting, Acapulco, 1999.
75. Chang L, Speck O, Miller E,
Braun J, Itti L, Ernst T. Increased usage of brain reserve capacity in patients
with HIV. Presented at the annual meeting of the International Society for
Magnetic Resonance in Medicine, Philadelphia, 1999.
76. Speck O, Chang L, Braun J,
Miller E, Ernst T. Gender differences in lateralization of activated brain
areas during a working memory task measured with fMRI. Presented at the annual
meeting of the International Society for Magnetic Resonance in Medicine,
Philadelphia, 1999.
77. McArthur JC, Enger C,
Jacobson L, Gore ME, Miller EN, Cohen BA, Becker JT, Kleeberger C, Kaslow R.
Influence of human major histocompatibility complex genes on the development of
HIV-associated dementia. Presented at the American Neurological Association,
1999.
78. Lam MN, Hinkin CH, Satz P,
Becker JT, Selnes OA, Sacktor NC, Cohen BA, Wesch J, Durvasula RS, Ishikawa S,
Castellon SA, Farinpour R, Hardy DJ, Miller EN for the Multicenter AIDS Cohort
Study (MACS). Practice effects and neuropsychological test performance:
longitudinal analysis of demographic and disease associated prognostic
indicators. Presented at the annual meeting of the International Neuropsychological
Society, Denver. Journal of the
International Neuropsychological Society, 6: 165, 2000.
79. Polk S, Jacobson LP, Sacktor
N, Jenkins F, Cohen B, Miller E, Muņoz A, for the Multicenter AIDS Cohort Study
(MACS). Investigation of the proposed protective effect of HHV-8 against
HIV-1-related dementia. Presented at the 7th Conference on Retroviruses and
Opportunistic Infections, San Francisco, 2000.
80. Chang L, Ernst T, Witt M,
DeSilva M, Jovicich J, Walot I, Ames N, Trivedi N, Miller E. Cerebral
metabolite abnormalities in antiretroviral-naive HIV patients before and after
HAART. Presented at the American Academy of Neurology, San Diego, 2000.
81. Yiannoutsos CT, Lee PL,
Chang L, Ernst T, Miller E, Kolson D, Lenkinski R, Marra C, Jarvic J, Richards
T, Schifitto G, Swindells S, McConnell J, Gonzalez G, Navia BA, for the proton
MRS consortium. Patterns of regional brain metabolism in AIDS Dementia Complex.
Presented at the American Academy of Neurology, San Diego, 2000.
82. Miller EN, Yiannoutsos CT,
Lee PL, Chang L, Ernst T, Marra CM, Jarvic J, Kolson D, Schifitto G, Lenkinski
R, Gonzalez RG, Navia BA and the HIV MRS Consortium. Brain metabolism and
neuropsychological function in AIDS Dementia Complex (ADC). Presented at the
Neuroscience of HIV Infection 2000, Edinburgh, 2000.
83. Yiannoutsos CT, Lee PL,
Chang L, Ernst T, Miller EN, Kolson D, Lenkinski R, Marra CM, Jarvik J, Richards T, Schifitto G, Swindells S,
McConnell J, Gonzalez RG, Navia BA.
Patterns of regional brain metabolism in AIDS Dementia Complex. Neuroscience of HIV Infection Edinburgh, UK,
June 22-24, 2000.
84. Sacktor NC, Skolasky RL,
Becker J, Cohen B, Miller EN, McArthur JC. Cerebrospinal fluid (CSF)
antiretroviral drug penetrance and treatment of HIV-associated cognitive
impairment. Presented at the Neuroscience of HIV Infection 2000, Edinburgh,
2000.
85. Navia BA, Yiannoutsos CT,
Change L, Marra CM, Miller E, Nath A, Berger J, Kolson D, Schifitto G, Ellis R,
Simpson D, Swindells S, Price R, Rajicic N. ACTG 301: A phase II randomized,
double-blind, placebo-controlled trial of memantine for AIDS Dementia Complex
(ADC). Neurology, 56 (8): A474-A475 Suppl. 3 Apr 24 2001.
86. Sacktor NC, Skolasky RL,
Tarwater PM, McArthur JC, Selnes OA, Becker J, Cohen B, Miller EN. The relationship between viral load response
to highly active antiretroviral therapy and psychomotor speed performance in
HIV+ homosexual men. Presented at the Neuroscience of HIV Infection 2002,
Dusseldorf, 2002.
87. Cloak CC, Chang L, Miller E,
Ernst T. Increased subcortical diffusion is associated with poorer cognitive
scores in HIV. Presented at the International Society for Magnetic Resonance in
Medicine (ISMRM), Toronto, 2003.
88. Cloak C, Chang L, Patterson
K, Grob C, Miller E, Ernst T. Sex-Differences in neuropsychological function
and brain morphometry in methamphetamine users.Oral Presentation at 65th Annual
Meeting of College on Problems of Drug Dependence (CPDD), Bal Harbour, Florida,
June 2003.
89. Cloak CC, Chang L, Conant K, Ernst T, Zimmerman L, Miller EN. Increased CSF monocyte
chemotactic protein-1 correlates with psychomotor slowing in HIV patients.
Presented at 33rd Annual Society for Neuroscience meeting, New
Orleans, November 2003.
90. Cloak CC, Chang L, Miller
EN, Ernst T. Poorer cognitive scores in HIV are associated with increased white
matter diffusion. Presented at HIV Molecular and Clinical Neuroscience
Workshop, Baltimore, September 2003.
91. Leckova K, Chang L, Cloak C,
Warren K, Miller E. Marijuana exacerbates psychomotor slowing in HIV. Presented
at the 10th Annual Society on NeuroImmune Pharmacology, Santa Fe,
New Mexico, March 2004.
92. Levine A, Miller E, Becker
J, Selnes O, Cohen B for the Multicenter AIDS Cohort Study. Regression
equations derived from non-clinical samples are useful in detecting cognitive
decline among a demographically similar HIV-infected cohort. Archives of Clinical Neuropsychology,
19(7), 944. Presented at the annual meeting of the National Academy of
Neuropsychology, Seattle, Washington, November 2004.
93. Hardy DJ, Borghi SW, Lodato
JE, Zolnikof B, Miller EN, Green MF, Parasuraman R, Hinkin CH. HIV, aging, and
cognitive task demands. Presented at the annual meeting of the National Academy
of Neuropsychology, Seattle, Washington, November 2004.
94. Schifitto G, Sacktor N,
Zhang J, Evans S, Simpson D, Millar L, Miller E, Smith E, Goodhead M, Clifford
D and the ACTG A5090 Team. A phase-II, placebo-controlled, double-blind placebo
controlled study of the selegiline transdermal system in the treatment of
HIV-associated cognitive impairment. Presented at the 13th
Conference on Retroviruses and Opportunistic Infections, Denver, Colorado,
February 2006.
95. Cole M, Margolick JB, Cox C,
Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Miller EN. (2007).
Longitudinal study of cognitive functioning in long-term asymptomatic
HIV-infected individuals. Journal of the International Neuropsychological
Society, 13 (S1), 220-221. Presented at the International Neuropsychological
Society, Portland, Oregon, February 2007.
96. Cole M, Margolick JB, Cox C,
Li X, Selnes OA, Martin EM, Becker JT, Aronow HA, Miller EN. Longitudinal study
of psychomotor speed and cognitive flexibility in long-term immunologically
asymptomatic HIV-infected individuals. Paper presented at the 14th
Conference on Retroviruses and Opportunistic Infections, Los Angeles, CA,
February 2007.
97. Wright MJ, Woo E,
Schmitter-Edgecombe M, Hinkin CH, Miller EN. The Item Specific Deficit approach
to evaluating verbal memory dysfunction: rationale, psychometrics and
application. Paper presented at the 37th Annual Meeting of the
International Neuropsychological Society, Atlanta, GA, February 2008.
98. Becker JT, Kingsley L,
Mullen J, Cohen B, Martin E, Miller E, Ragin A, Sacktor N, Selnes OA, Visscher
BR. Vascular risk factors and human immunodeficiency virus convey different
risks for cognitive dysfunction in gay/bisexual men. Presented at the 61st
Annual Meeting of the American Academy of Neurology, Seattle, WA, April 2009.
99. Sacktor N, Skolasky R,
Selnes O, Becker J, Cohen B, Martin E, Visscher B, Miller E. Longitudinal
changes in psychomotor speed test performance among HIV+ and HIV- individuals:
the impact of age and serostatus. Presented at the 61st Annual
Meeting of the American Academy of Neurology, Seattle, WA, April 2009.
100. Wright MJ, Woo E, Foley J,
Ettenhofer ML, Cottingham ME, Gooding AL, Jang J, Kim MS, Castellon SA, Miller
EN, Hinkin CH. HAART adherence and the expression of verbal memory impairment
in HIV. Presented at the American Neuropsychiatric Association (ANPA) Annual
Meeting, Tampa, Florida, March 2010.
101. Levine A, Service S, Miller
E, Singer E, Freimer N. Genome wide association study of HIV-associated
neurocognitive disorders: preliminary report. Presented at the 16th annual
meeting of the Society of NeuroImmune Pharmacology, Manhattan Beach,
California, April 2010.
102. Becker JT, Cohen B, Martin
E, Miller E, Sanders J, Ragin A, Sacktor N, Selnes O, Carmichael O. Predictors
of ventricular volume in HIV disease. Presented at American Academy of
Neurology (AAN) Annual Meeting, Toronto, Ontario, April 2010.
103. Mateen FJ, Shinohara RT,
Carone M, Sacktor N, Miller EN, McArthur JC, Jacobson LP for the Multicenter
AIDS Cohort Study. Incidence of stroke and all neurological disorders by age in
HAART-treated human immunodeficiency virus-positive versus HIV-negative
individuals. Presented at American Academy of Neurology (AAN) Annual Meeting,
Honolulu, Hawaii, April 2011.
104. Vo Q, Cox C, Li X, Jacobson
L, McKaig R, Miller E. Changes in performance on neuropsychological tests
before and after HIV-1 SC: 25 years of data from the Multicenter AIDS Cohort
Study (MACS). Presented at the 19th Conference on Retroviruses and
Opportunistic Infections, Seattle, Washington, March 2012.
105. Becker J, Ragin A,
Teverovisky L, Goodkin K, Kingsley L, Martin E, Miller E, Sacktor N, Selnes O,
Shah N for the Multicenter AIDS Cohort Study. White matter lesions, gray matter
atrophy and cognition in HIV disease. Presented at the 19th
Conference on Retroviruses and Opportunistic Infections, Seattle, Washington,
March 2012.
106. Levine A, Service S, Miller
E, Singer E, Shapshak P, Friemer N. Genome-wide Association Study of
HIV-Related Neurocognitive Decline and Dementia. Presented at the 19th
Conference on Retroviruses and Opportunistic Infections, Seattle, Washington,
March 2012.
107. Mateen FJ, Shinohara RT,
Carone M, Sacktor N, Miller EN, McArthur JC, Jacobson LP for the Multicenter
AIDS Cohort Study. Attributable Burden of Neurological Disease in Older
HIV-Positive versus HIV-Negative Men: Findings from the Multicenter AIDS Cohort
Study (MACS), 1997-2009. Presented at American Academy of Neurology (AAN)
Annual Meeting, New Orleans, Louisiana, April 2012.
108. Goodkin K, Miller EN, Cox C,
Reynolds S, Ostrow D, Selnes O, Becker JT for the Multi-Center AIDS Cohort
Study. Older age and neurocognitive performance in the Multi-Center AIDS Cohort
Study. Presented at the XIX International AIDS Conference, Washington, DC, July
2012.
109. Levine AJ, Reynolds S, Cox
C, Miller E, Service S, Becker J, Sacktor N, Martin E, for the Multicenter AIDS
Cohort Study. Longitudinal analysis of interactive effects of host genotype,
stimulant use, and HIV status upon neurocognitive functioning. Presented at the
11th International Society for NeuroVirology (ISNV) Symposium, New
York City, May 2012.
110. Goodkin K, Miller EN, Cox C,
Reynolds S, Ostrow D, Selnes O, Becker JT for the Multicenter AIDS Cohort
Study. Older age and neurocognitive function in the Multi-Center AIDS Cohort
Study. Presented at the 20th Conference on Retroviruses and
Opportunistic Infections, Atlanta, GA, March 2013.
111. Smith B, Skolasky R, Becker
J, Martin E, Miller E, Selnes O, Margolick JB, Sacktor NC for the Multicenter
AIDS Cohort Study. Longitudinal association of HIV-associated neurocognitive
disorder with frailty in HIV-1-seropositive men. Presented at the 20th
Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, March
2013.
112. Chang L, Holt J, Lohaugen G,
Tanizaki N, Jiang C, Miller E, Skranes J, Ernst T. Working memory (WM) training
improves cognitive performance and normalizes brain activation on functional
MRI in HIV patients. Presented at the 2nd Meeting of the
Entertainment Software and Cognitive Neurotherapeutics Society (ESCoNS), Los
Angeles, CA, March 2013.
113. Levine AJ, Horvath S, Miller
EN, Singer EJ, Shapshak P, Baldwin G, Martinez-Maza O, Witt M, Langfelder P.
Transcriptome analysis of HIV-infected peripheral blood monocytes: genes and
networks associated with neurocognitive functioning. Presented at the
International Society for NeuroVirology, Washington, DC, October, 2013.
114. Chang L, Holt J, Tanizaki N,
Douet V, Jiang C, Lohaugen G, Miller E, Lee K, Walker C, Skranes J, Ernst T.
Working memory training improves cognitive performance and normalizes brain
activation on functional MRI in HIV patients. Presented at the 52nd
meeting of the American College of Neuropsychopharmacology (ACNP), Hollywood,
Florida, December 2013.
115. Becker JT, Kingsley L,
Molsberry S, Reynolds S, Aronow A, Levine AJ, Martin E, Miller EN, Munro CA,
Ragin A, Sacktor N, Selnes O. Recruitment differences and survival biases among
men with neuropsychological evaluations in the Multicenter AIDS Cohort Study
(1987-2012). Presented at the International Society for NeuroVirology,
Washington, DC, October, 2013.
116. Becker JT, Martinson JJ,
Penugonda S, Kingsley L, Molsberry S, Wolinsky S, Reynolds S, Aronow A, Levine
A, Martin E, Miller EN, Munro CA, Ragin A, Sacktor N. Allele frequencies of the
Apolipoprotein E gene in the Multicenter AIDS Cohort Study as a function of
recruitment cohort, race, survivorship and neuropsychological outcomes.
Presented at the International Society for NeuroVirology, Washington, DC,
October, 2013.
117. Martinez FW, Gibson J,
Birath JB, Lopez WD, Insua-Rieger S, Daly CJ, Miller EN, Reinhard MJ,
Cottingham ME, Hardy D, Cox C, Reynolds S, Martin E, Becker JT, Selnes OA,
Manly J, Wright MJ. The role of academic level and achievement in
neuropsychological test performances of minorities. Presented at the
International Neuropsychological Society, Seattle, WA, February 2014.
118. Becker JT, Kingsley LA,
Popov M, Shah N, Levine AJ, Martin EM, Miller EN, Munro CA, Ragin A, Sacktor N.
The effects of age and study cohort on brain structure among men with HIV
disease. Presented at the Conference on Retroviruses and Opportunistic
Infections, Boston, MA, March 2014.
119. Chang L, Lohaugen G,
Tanizaki N, Walker C, Lee K, Douet V, Zhang X, Lim A, Castillo D, Andres T,
Holmes N, Miller E, Skranes J, Ernst T. Adaptive working memory training in HIV
patients. American Neurological Association Annual Meeting, Baltimore, MD,
October 2014.
120. Morris A, Kingsley L, Gingo
M, Fitzpatrick M, Detels R, Martinez-Maza O, Miller E, Alger JR, Kleerup E,
Becker JT. Smoking and abnormal lung function alter brain structure and
function in HIV. Conference on Retroviruses and Opportunistic Infections,
Seattle, WA, February 2015.
121. Monroe A, Zhang L, Jacobson
L, Plankey M, Brown T, Munro C, Miller E, Martin E, Becker J, Li Y, Sacktor N.
The impact of physical activity on cognition in men with and without HIV.
Conference on Retroviruses and Opportunistic Infections, Seattle, WA, February
2015.
122. Sacktor N, Reynolds S,
Skolasky R, Munro C, Becker J, Martin E, Ragin A, Levine A, Miller E. Frequency
of HIV-associated neurological disorders over four years of follow-up: results
from the Multicenter AIDS Cohort Study. American Academy of Neurology,
Washington, DC, April 2015.
123. Akhtar-Khaleel W, Cook R,
Sacktor N, Miller E, Price C, Surkan PJ, Beyth R, Teplin L, Manini TM, Stall R,
Shoptaw S, Plankey M. The association of mid-life smoking status on processing
speed and mental flexibility among HIV-seropositive and seronegative older men:
the Multicenter AIDS Cohort Study. 6th International Workshop on HIV and Aging,
Washington, DC, October 2015.
124. Maki PM, Rubin LH, Springer
G, Sacktor N, Miller EN, Valcour V, Young M, Becker JT, Seaberg EC, Martin E.
Male/Female differences in cognitive function in HIV+ individuals. Presented at
Conference on Retroviruses and Opportunistic Infections, Boston, MA, February
2016.
125. Becker JT, Popov M, Kingsley
L, Barrington F, Levine A, Martin E, Miller E, Munro C, Ragin A, Sacktor N.
Cardiovascular risk factors and the rate of change in brain structure in HIV
disease. Presented at Conference on Retroviruses and Opportunistic Infections, Boston,
MA, February 2016.
126. Wang Z, Cheng Y, Molsberry
SA, Kingsley L, Levine A, Martin E, Miller E, Munro C, Ragin AB, Sacktor N,
Seaberg E, Becker JT. Classifying cognitive status in HIV-infected men by
multivariate normative comparison. To be presented at Conference on
Retroviruses and Opportunistic Infections, Boston, MA, March 2018.
127. Molsberry SA, Cheng Y,
Kingsley L, Jacobson L, Levine A, Martin E, Miller E, Munro C, Ragin AB,
Sacktor N, Becker JT. Neuropsychological phenotypes in the MACS. To be presented
at Conference on Retroviruses and Opportunistic Infections, Boston, MA, March
2018.
Current as March 11, 2019